Lilly's new diabetes drug doubled sales expectations. It may also be used to treat obesityMarket Watch • 11/01/22
Why Eli Lilly's Third-Quarter Beat Wasn't Enough To Save Its GuidanceInvestors Business Daily • 11/01/22
Lilly's new Type 2 diabetes drug had $187 million in sales in the third quarterMarket Watch • 11/01/22
Lilly Reports Solid Third-Quarter 2022 Financial Results and Continued Pipeline ProgressPRNewsWire • 11/01/22
Lilly commits $92.5 million to Purdue to establish an innovative pharmaceutical manufacturing scholarship program and to extend research collaborationPRNewsWire • 10/27/22
Lilly Confirms Date and Conference Call for Third-Quarter 2022 Financial Results AnnouncementPRNewsWire • 10/19/22